Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial
Gennaro D'Amico, Flavia Politi, Alberto Morabito, Adele D'Antoni, Daniela Guerrera, Gandolfo Giannuoli, Mario Traina, Giovanni Vizzini, Linda Pasta, Luigi Pagliaro – 30 December 2003 – β‐Blockers and sclerotherapy prevent long‐term upper digestive rebleeding in cirrhosis but they seem ineffective for early rebleeding. We compared octreotide with a placebo for the prevention of early rebleeding in cirrhotic patients.